Abstract: Herein disclosed is receiving predetermined content, receiving a request to transform the predetermined content into a derivative work, receiving a requested theme for the derivative work, using generative artificial intelligence to create the derivative work generated as a function of the predetermined content and the requested theme, determining if the generated derivative work is approved based on a machine learning model configured to determine a content approval score as a function of content owner preferences, in response to determining the generated derivative work is approved, applying a digital watermark to the approved derivative work, configuring an authorization server to govern use of the approved derivative work based on the digital watermark and providing user access to the authorized derivative work. The requested theme may be determined using a Large Language Model (LLM) and a chatbot interview. The generative artificial intelligence may comprise a diffusion model.

Abstract: Biomarkers, methods, devices, reagents, systems, and kits used to assess the quality of a sample collected from a subject are provided. Such biomarkers, methods, devices, reagents, systems, and kits may be useful in evaluating acceptability of sample handling and/or consistency of sample handling across a plurality of samples.

Abstract: Biomarkers, methods, devices, reagents, systems, and kits used to assess the quality of a sample collected from a subject are provided. Such biomarkers, methods, devices, reagents, systems, and kits may be useful in evaluating compliance with fasting protocols.

Abstract: Described herein are compositions and methods for reducing the variability of inter-sample analyte measurements from a biological matrix. In some embodiments, the present disclosure relates to methods for reducing the variability in the inter-sample levels of one or more proteins from a biological sample as measured by a proteomic assay.

Abstract: This invention allows the communication of mission critical data to devices that communicate within the same, or a separately connected, power distribution system. Devices operate by being connected to a power distribution system, subsystem, and or different but connected power system. Each device has a specific similar or different communication platform, architecture, protocol method and or process for performing a function and or distributing data. The invention allows all devices connected through the power system to communicate to one, some or all other devices as wanted; regardless of the type of architecture, protocol, platform, or type of power on the power system. Power systems can be connected by power or communication and can be separate. All powered devices utilizing the invention seamlessly operate, communicate and network for their specified reason(s) in their native formats without any needs of communication wiring using the power distribution system as the medium of communication.

Abstract: This invention allows the communication of mission critical data to devices that communicate within the same, or a separately connected, power distribution system. Devices operate by being connected to a power distribution system, subsystem, and or different but connected power system. Each device has a specific similar or different communication platform, architecture, protocol method and or process for performing a function and or distributing data. The invention allows all devices connected through the power system to communicate to one, some or all other devices as wanted; regardless of the type of architecture, protocol, platform, or type of power on the power system. Power systems can be connected by power or communication and can be separate. All powered devices utilizing the invention seamlessly operate, communicate and network for their specified reason(s) in their native formats without any needs of communication wiring using the power distribution system as the medium of communication.

Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.

Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.

Abstract: A diagnostic biochip comprising a solid support to which one or more specific nucleic acid ligands is attached in a spatially defined manner is provided. Each nucleic acid ligand binds specifically and avidly to a particular target molecule contained within a test mixture, such as a bodily fluid. Also provided are methods for the preparation of nucleic acid ligand biochips. Further, methods for the use of the nucleic acid ligand biochip in diagnosis of a medical condition and quantitative detection of a target molecule are provided.

Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.

Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.

Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.

Abstract: Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.